Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CG Therapeutics Inc.

Latest From CG Therapeutics Inc.

Partnering Interest In Infectious Disease Space Showing Promise Beyond HCV Hotspot

Antiviral agents and vaccines for indications beyond the red-hot hepatitis C indication highlight the infectious diseases track at this year’s Therapeutic Area Partnerships conference.

BioPharmaceutical Clinical Trials

Start-Up Previews

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Start-Ups Against Inflammation," features profiles of Asphleia Pharmaceuticals, Calistoga Pharmaceuticals, ProtAb Ltd., and Resolvyx Pharmaceuticals. Plus these Start-Ups Across Health Care: CG Therapeutics, Healionics, Mpathy Medical Devices and Pronostics.

CG Therapeutics Inc.

It sometimes happens that a medicine developed for one purpose is discovered to work wonderfully well in other, initially unanticipated indications. The founders of CG Therapeutics believe they can benefit from just such serendipity. The start-up company is developing a molecule first pursued at Ohio State University as a long-acting contraceptive some 30 years ago, now as a cancer vaccine meant to treat solid tumors.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • CG Therapeutics Inc.
  • Senior Management
  • Denise Harrison, Pres. & CEO
    Gavin D Clarke, VP, Bus. Dev.
    Thomas P Hopp, PhD, VP, R&D
  • Contact Info
  • CG Therapeutics Inc.
    Phone: (206) 336-5604
    2815 Eastlake Ave. E.
    Ste. 300
    Seattle, WA 98102